21
FRITZSON Art, BEZRUKOV Semion, PALKA Sean: SYSTÈMES ET PROCÉDÉS DIDENTIFICATION ET DATTÉNUATION DE RISQUES RELATIFS À LA SÉCURITÉ DES INFORMATIONS, SYSTEMS AND METHODS FOR IDENTIFYING AND MITIGATING INFORMATION SECURITY RISKS. FRITZSON Art, BEZRUKOV Semion, PALKA Sean, WIELAND Charles F III, May 24, 2012: WO/2012/068255 (17 worldwide citation)

Methods and systems for Sustained Testing and Awareness Refresh against Phishing threats (STAR*PhishTM) are disclosed. In an embodiment, a method assigns schemes and unique identifiers to target e-mail addresses associated with a user accounts. The method delivers e-mail messages to the targeted e-m ...


22
GOLDBLUM Adam Aaron, DOZZO Paola, KANE Timothy Robert, AGGEN James Bradley, LINSELL Martin Sheringham, HILDEBRANDT Darin James, GLIEDT Micah James: ANALOGUES DAMINOGLYCOSIDES ANTIBACTÉRIENS, ANTIBACTERIAL AMIINOGLYCOSIDE ANALOGS. ACHAOGEN, GOLDBLUM Adam Aaron, DOZZO Paola, KANE Timothy Robert, AGGEN James Bradley, LINSELL Martin Sheringham, HILDEBRANDT Darin James, GLIEDT Micah James, WAGNER Emily W, May 24, 2012: WO/2012/067978 (16 worldwide citation)

Compounds having antibacterial activity are disclosed. The compounds have a structure including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Q1 and Q2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical com ...


23
ACKERMANN Douglas Michael, PALANKER Daniel, LOUDIN James, SMITH Garrett Cale, MCCRAY Victor Wayne, FELKINS Brandon Mcnary: SYSTÈMES ET PROCÉDÉS POUR TRAITER LA SÉCHERESSE OCULAIRE, SYSTEMS AND METHODS FOR TREATMENT OF DRY EYE. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, ACKERMANN Douglas Michael, PALANKER Daniel, LOUDIN James, SMITH Garrett Cale, MCCRAY Victor Wayne, FELKINS Brandon Mcnary, GEHLING Stephanie, May 24, 2012: WO/2012/068247 (15 worldwide citation)

A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The stimulation system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. In various embodiments, the components of the con ...


24
AKLOG Lishan, CHIN Albert K, DEGUZMAN Brian, GLENNON Michael: DISPOSITIFS DE MAINTIEN DE TISSUS ET PROCÉDÉS DUTILISATION, TISSUE RESTRAINING DEVICES AND METHODS OF USE. PAVILION MEDICAL INNOVATIONS, AKLOG Lishan, CHIN Albert K, DEGUZMAN Brian, GLENNON Michael, PHAM Chinh H, May 24, 2012: WO/2012/068541 (13 worldwide citation)

Tissue restraining systems and devices as well as methods of using these devices are disclosed herein. According to aspects illustrated herein, there is provided a tissue restraining device that may include a first anchor having one or more contact points along a portion of the first anchor in a spa ...


25
WOODARD James A Jr, LESKO Jason R: INSTRUMENT DE SUTURE LAPAROSCOPIQUE AVEC PINCES À AIGUILLES À DOUBLE ACTION, LAPAROSCOPIC SUTURING INSTRUMENT WITH DUAL-ACTION NEEDLE GRASPERS. ETHICON ENDO SURGERY, WOODARD James A Jr, LESKO Jason R, ULMER Andrew B, May 24, 2012: WO/2012/068002 (13 worldwide citation)

A suture needle driving instrument comprises a shaft, an end effector, and a grasping actuation assembly. The end effector is located at the distal end of the shaft and includes a pair of grasping arms. Each grasping arm comprises a respective pair of jaws. Each pair of jaws is operable to cooperate ...


26
CHALTIN Patrick, CHRIST Frauke, DEBYSER Zeger, DE MAEYER Marc, MARCHAND Arnaud, MARCHAND Damien, VOET Arnout: NOUVEAUX COMPOSÉS ANTIVIRAUX, NOVEL ANTIVIRAL COMPOUNDS. KATHOLIEKE UNIVERSITEIT LEUVEN, CHALTIN Patrick, CHRIST Frauke, DEBYSER Zeger, DE MAEYER Marc, MARCHAND Arnaud, MARCHAND Damien, VOET Arnout, SCHREIBER Ina, May 24, 2012: WO/2012/065963 (12 worldwide citation)

The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting 5 properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such ...


27
LADIWALA Asif, PIERACCI John: ENRICHISSEMENT ET CONCENTRATION DISOFORMES DE PRODUIT CHOISIS PAR LIAISON SURCHARGÉE ET CHROMATOGRAPHIE DÉLUTION, ENRICHMENT AND CONCENTRATION OF SELECT PRODUCT ISOFORMS BY OVERLOADED BIND AND ELUTE CHROMATOGRAPHY. BIOGEN IDEC, LADIWALA Asif, PIERACCI John, STEFFE Eric K, May 24, 2012: WO/2012/068134 (12 worldwide citation)

Disclosed is a method for enhancing or increasing the concentration of biological product in a final mixture, wherein said biological product has one or more selected characteristics, wherein said method comprises: (a) allowing an initial mixture of biological products with and without said selected ...


28
DONG Haijun, CAI Suixiong, TIAN Ye Edward, CHEN Lei, YU Zenghui, YIN Feng, BI Sheng, LIU Lijun, WU Lizhen: 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-A]PYRIDINES EN TANT QUINHIBITEURS DE LA PROLIFÉRATION CELLULAIRE ET LEUR UTILISATION, 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF. IMPACT THERAPEUTICS, DONG Haijun, CAI Suixiong, TIAN Ye Edward, CHEN Lei, YU Zenghui, YIN Feng, BI Sheng, LIU Lijun, WU Lizhen, SHANGHAI PATENT & TRADEMARK LAW OFFICE, May 24, 2012: WO/2012/065297 (12 worldwide citation)

Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1-R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation. Therefore, compounds of the invention may be used to treat clinical conditions in which u ...


29
CAI Suixiong, TIAN Ye Edward, DONG Haijun, CHEN Lei, YU Zenghui, YIN Feng, BI Sheng, LIU Lijun, WU Lizhen: 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-A]PYRIDINES EN TANT QUINHIBITEURS DE LA PROLIFÉRATION CELLULAIRE ET LEUR UTILISATION, 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF. IMPACT THERAPEUTICS, CAI Suixiong, TIAN Ye Edward, DONG Haijun, CHEN Lei, YU Zenghui, YIN Feng, BI Sheng, LIU Lijun, WU Lizhen, SHANGHAI PATENT & TRADEMARK LAW OFFICE, May 24, 2012: WO/2012/065546 (11 worldwide citation)

Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1-R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation. Therefore, compounds of the invention may be used to treat clinical conditions in which u ...


30
JAIN Rakesh Kumar, BOUCHER Yves, CHAUHAN Vikash Pal Singh, DIOP FRIMPONG Benjamin, KRANE Stephen, CRANE Alan L, LANGER Robert Samuel: NOUVELLES COMPOSITIONS ET UTILISATIONS DAGENTS HYPOTENSEURS DANS LE TRAITEMENT DU CANCER, NOVEL COMPOSITIONS AND USES OF ANTI-HYPERTENSION AGENTS FOR CANCER THERAPY. THE GENERAL HOSPITAL CORPORATION, XTUIT PHARMACEUTICALS, JAIN Rakesh Kumar, BOUCHER Yves, CHAUHAN Vikash Pal Singh, DIOP FRIMPONG Benjamin, KRANE Stephen, CRANE Alan L, LANGER Robert Samuel, RESNICK David S, May 24, 2012: WO/2012/068531 (10 worldwide citation)

Methods and compositions for improving the delivery and/or efficacy of cancer therapeutics are disclosed. Methods and compositions for treating or preventing a cancer (e.g., a solid tumor such as a desmoplastic tumor) by administering to a subject an antihypertensive agent, as a single agent or comb ...